Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.71
Delayed Data
As of May 26
 -0.01 / -1.39%
Today’s Change
0.65
Today|||52-Week Range
1.04
+1.43%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.72
Today’s open0.72
Day’s range0.70 - 0.74
Volume595,152
Average volume (3 months)572,241
Market cap$129.3M
Dividend yield--
Data as of 4:00pm ET, 05/26/2015

Growth & Valuation

Earnings growth (last year)-57.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.83

Competitors

 Today’s
change
Today’s
% change
EPRSEPIRUS Biopharmaceut...-0.10-1.81%
LPCNLipocine Inc+0.01+0.14%
AVEOAveo Pharmaceuticals...-0.04-1.73%
NERVMinerva Neuroscience...-0.10-1.95%
Data as of 3:59pm ET, 05/26/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$18.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers